Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy manufacturing.

Collectively, the data from in vitro and in vivo studies using FUS, TDP-43, and C9orf72 models demonstrate that hUPF1 holds significant potential for treating the majority of patients with ALS and ...

Since my last writing, Meta Platforms has delivered a strong FQ1 earnings report and updated its AI growth strategy. Click to ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Alibaba Group Holding (NYSE:BABA) releases its first quarter earnings on Thursday, May 15. Wall Street is expecting the ...

Home > Pressemitteilung: Medicine meets technology: promoting ... Kurt Alten Foundation supports clinical scientist at MHH in transferring innovative medical-technological approaches to improve liver ...

Bihar Health Minister Mangal Pandey said that a special search campaign would be launched to trace Kalazar patients from the first week of June across the state.

At Vector’s recent Remarkable symposium, dozens of researchers shared breakthroughs spanning everything from large model ...

AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic ...